These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7603239)

  • 21. Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.
    Izumi Y; Ami Y; Matsuo K; Someya K; Sata T; Yamamoto N; Honda M
    J Virol; 2003 Dec; 77(24):13248-56. PubMed ID: 14645581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune mechanisms associated with protection from vaginal SIV challenge in rhesus monkeys infected with virulence-attenuated SHIV 89.6.
    Miller CJ; Abel K
    J Med Primatol; 2005 Oct; 34(5-6):271-81. PubMed ID: 16128922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paradigm change in immune correlation: cellular or humoral?
    Matsuo K; Yamamoto N
    Expert Rev Vaccines; 2010 Sep; 9(9):985-7. PubMed ID: 20822339
    [No Abstract]   [Full Text] [Related]  

  • 24. AIDS vaccines. At conference, hope for success is further attenuated.
    Cohen J
    Science; 1994 Nov; 266(5188):1154. PubMed ID: 7973692
    [No Abstract]   [Full Text] [Related]  

  • 25. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live attenuated SIV vaccines are not effective in a postexposure vaccination model.
    Linhart H; Gundlach BR; Sopper S; Dittmer U; Mätz-Rensing K; Kuhn EM; Müller J; Hunsmann G; Stahl-Hennig C; Uberla K
    AIDS Res Hum Retroviruses; 1997 May; 13(7):593-9. PubMed ID: 9135877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an AIDS vaccine using Sendai virus vectors.
    Ishii H; Matano T
    Vaccine; 2015 Nov; 33(45):6061-5. PubMed ID: 26232346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge.
    Gabriel B; Fiebig U; Hohn O; Plesker R; Coulibaly C; Cichutek K; Mühlebach MD; Bannert N; Kurth R; Norley S
    Virology; 2016 Feb; 489():1-11. PubMed ID: 26685794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candidate vaccines protect macaques against primate immunodeficiency viruses.
    Stott J; Hu SL; Almond N
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative approach to retroviral vaccines.
    Burny A
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):389-92. PubMed ID: 8882316
    [No Abstract]   [Full Text] [Related]  

  • 31. Protection against late-onset AIDS in macaques prophylactically immunized with a live simian HIV vaccine was dependent on persistence of the vaccine virus.
    Mackay GA; Liu Z; Singh DK; Smith MS; Mukherjee S; Sheffer D; Jia F; Adany I; Sun KH; Dhillon S; Zhuge W; Narayan O
    J Immunol; 2004 Sep; 173(6):4100-7. PubMed ID: 15356160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines. Monkey puzzles.
    Cohen J
    Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef.
    Sawai ET; Hamza MS; Ye M; Shaw KE; Luciw PA
    J Virol; 2000 Feb; 74(4):2038-45. PubMed ID: 10644378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress in vaccination against AIDS].
    Burny A
    Bull Mem Acad R Med Belg; 1995; 150(3-4):145-53; discussion 153-5. PubMed ID: 8845793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost.
    Gorelick RJ; Benveniste RE; Lifson JD; Yovandich JL; Morton WR; Kuller L; Flynn BM; Fisher BA; Rossio JL; Piatak M; Bess JW; Henderson LE; Arthur LO
    J Virol; 2000 Dec; 74(24):11935-49. PubMed ID: 11090194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
    Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
    Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AIDS doctors push for live-virus vaccine trials.
    McCarthy M
    Lancet; 1997 Oct; 350(9084):1082. PubMed ID: 10213561
    [No Abstract]   [Full Text] [Related]  

  • 40. AIDS 1995. Vaccines and immunology: overview.
    Montelaro RC; Wigzell H
    AIDS; 1995; 9 Suppl A():S111-2. PubMed ID: 8819577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.